BB Biotech AG announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was CHF 235.765 million compared to CHF 284,000 a year ago. Net income was CHF 220.948 million compared to net loss of CHF 757.954 million a year ago. Basic earnings per share from continuing operations was CHF 3.99 compared to basic loss per share from continuing operations of CHF 13.68 a year ago.